Boston Common Asset Management’s Core Laboratories CLB Stock Holding History

Boston Common Asset Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-22,002	Closed	-$2.47M	–	192
2016 Q3	$2.47M	Sell	22,002 -1,060	-5%	-$122K	0.13%	155
2016 Q2	$2.86M	Sell	23,062 -8,911	-28%	-$1.08M	0.16%	148
2016 Q1	$3.59M	Buy	31,973 +3,786	+13%	+$393K	0.2%	135
2015 Q4	$3.06M	Sell	28,187 -3,407	-11%	-$390K	0.17%	143
2015 Q3	$3.15M	Sell	31,594 -12,866	-29%	-$1.4M	0.19%	138
2015 Q2	$5.07M	Buy	44,460 +1,995	+5%	+$242K	0.27%	114
2015 Q1	$4.44M	Buy	42,465 +16,975	+67%	+$1.81M	0.24%	129
2014 Q4	$3.07M	Buy	25,490 +3,520	+16%	+$462K	0.17%	149
2014 Q3	$3.21M	Buy	21,970 +1,760	+9%	+$272K	0.18%	152
2014 Q2	$3.38M	Buy	+20,210	New	+$3.6M	0.18%	143

Other funds holding CLB

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Wedgewood Partners St Louis, Missouri $484M AUM 16.04% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Boston Common Asset Management's CLB Position: Q4 2016 in Review

Boston Common Asset Management sold out of Core Laboratories (CLB) in Q4 2016, closing a stake of 22,002 shares — an estimated $2.47M sold.

Boston Common Asset Management first reported a position in CLB in Q2 2014 and held it in 10 quarters. The position peaked at $5.07M in Q2 2015. 373 funds tracked by Wall St. Rank hold CLB as of Q4 2016.

Boston Common Asset Management reported no remaining Core Laboratories position as of Q4 2016 after selling out during the quarter.
Boston Common Asset Management sold 22,002 Core Laboratories shares in Q4 2016, an estimated $2.47M.
Boston Common Asset Management first reported a position in Core Laboratories in Q2 2014 and held it in 10 quarters.
Boston Common Asset Management's Core Laboratories position peaked at $5.07M in Q2 2015.
373 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2016.

Based on Boston Common Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.